Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ramon Parsons

Showing results (61-70 of 79) with videos related to

Pageof 8
Sort By:
Cancer Cell|February 16, 2005
Lack of PTEN sequesters CHK1 and initiates genetic instabilityJanusz Puc, Megan Keniry, Hong Shen Li, et al.
The American Journal of Pathology|April 4, 2009
Gab2-mediated signaling promotes melanoma metastasisBasil Horst, Sofia K Gruvberger-Saal, Benjamin D Hopkins, et al.
Molecular Cancer Research : MCR|March 11, 2020
<i>PIK3CA</i> and <i>p53</i> Mutations Promote 4NQO-Initated Head and Neck Tumor Progression and Metastasis in MiceDarío García-Carracedo, Yi Cai, Wanglong Qiu, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 21, 2002
HLTF gene silencing in human colon cancerHelen R Moinova, Wei-Dong Chen, Lanlan Shen, et al.
The American Journal of Pathology|December 20, 2008
Irs2 inactivation suppresses tumor progression in Pten+/- miceMatthias Szabolcs, Megan Keniry, Laura Simpson, et al.
Genes & Development|May 1, 2013
Survival factor NFIL3 restricts FOXO-induced gene expression in cancerMegan Keniry, Maira M Pires, Sarah Mense, et al.
Cell Reports|April 6, 2022
Altered BAF occupancy and transcription factor dynamics in PBAF-deficient melanomaSaul Carcamo, Christie B Nguyen, Elena Grossi, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 25, 2007
Poor prognosis in carcinoma is associated with a gene expression signature of aberrant PTEN tumor suppressor pathway activityLao H Saal, Peter Johansson, Karolina Holm, et al.
Cancer Discovery|July 24, 2021
AKT Degradation Selectively Inhibits the Growth of PI3K/PTEN Pathway-Mutant Cancers with Wild-Type KRAS and BRAF by Destabilizing Aurora Kinase BJia Xu, Xufen Yu, Tiphaine C Martin, et al.
BMC Cancer|August 4, 2016
Integrated molecular pathway analysis informs a synergistic combination therapy targeting PTEN/PI3K and EGFR pathways for basal-like breast cancerQing-Bai She, Sofia K Gruvberger-Saal, Matthew Maurer, et al.
Pageof 8

Showing results (61-70 of 79) with videos related to

Sort By:
Pageof 8
Cancer Cell|February 16, 2005
Lack of PTEN sequesters CHK1 and initiates genetic instabilityJanusz Puc, Megan Keniry, Hong Shen Li, et al.
The American Journal of Pathology|April 4, 2009
Gab2-mediated signaling promotes melanoma metastasisBasil Horst, Sofia K Gruvberger-Saal, Benjamin D Hopkins, et al.
Molecular Cancer Research : MCR|March 11, 2020
<i>PIK3CA</i> and <i>p53</i> Mutations Promote 4NQO-Initated Head and Neck Tumor Progression and Metastasis in MiceDarío García-Carracedo, Yi Cai, Wanglong Qiu, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 21, 2002
HLTF gene silencing in human colon cancerHelen R Moinova, Wei-Dong Chen, Lanlan Shen, et al.
The American Journal of Pathology|December 20, 2008
Irs2 inactivation suppresses tumor progression in Pten+/- miceMatthias Szabolcs, Megan Keniry, Laura Simpson, et al.
Genes & Development|May 1, 2013
Survival factor NFIL3 restricts FOXO-induced gene expression in cancerMegan Keniry, Maira M Pires, Sarah Mense, et al.
Cell Reports|April 6, 2022
Altered BAF occupancy and transcription factor dynamics in PBAF-deficient melanomaSaul Carcamo, Christie B Nguyen, Elena Grossi, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 25, 2007
Poor prognosis in carcinoma is associated with a gene expression signature of aberrant PTEN tumor suppressor pathway activityLao H Saal, Peter Johansson, Karolina Holm, et al.
Cancer Discovery|July 24, 2021
AKT Degradation Selectively Inhibits the Growth of PI3K/PTEN Pathway-Mutant Cancers with Wild-Type KRAS and BRAF by Destabilizing Aurora Kinase BJia Xu, Xufen Yu, Tiphaine C Martin, et al.
BMC Cancer|August 4, 2016
Integrated molecular pathway analysis informs a synergistic combination therapy targeting PTEN/PI3K and EGFR pathways for basal-like breast cancerQing-Bai She, Sofia K Gruvberger-Saal, Matthew Maurer, et al.
Pageof 8